Banner
  • Revenue Cycle Management
  • COVID-19
  • Reimbursement
  • Diabetes Awareness Month
  • Risk Management
  • Patient Retention
  • Staffing
  • Medical Economics® 100th Anniversary
  • Coding and documentation
  • Business of Endocrinology
  • Telehealth
  • Physicians Financial News
  • Cybersecurity
  • Cardiovascular Clinical Consult
  • Locum Tenens, brought to you by LocumLife®
  • Weight Management
  • Business of Women's Health
  • Practice Efficiency
  • Finance and Wealth
  • EHRs
  • Remote Patient Monitoring
  • Sponsored Webinars
  • Medical Technology
  • Billing and collections
  • Acute Pain Management
  • Exclusive Content
  • Value-based Care
  • Business of Pediatrics
  • Concierge Medicine 2.0 by Castle Connolly Private Health Partners
  • Practice Growth
  • Concierge Medicine
  • Business of Cardiology
  • Implementing the Topcon Ocular Telehealth Platform
  • Malpractice
  • Influenza
  • Sexual Health
  • Chronic Conditions
  • Technology
  • Legal and Policy
  • Money
  • Opinion
  • Vaccines
  • Practice Management
  • Patient Relations
  • Careers

NIH Updates Testing, Treatment Guidelines During Co-circulation of Influenza and COVID-19

Slideshow

The new guideline section stresses that testing is the only way to accurately discriminate between the 2 viruses and advises on influenza vaccination and treatment.

The National Institutes of Health (NIH) on October 22, 2020 made updates to its COVID-19 Treatment Guidelines that provide information for clinicians in communities where influenza viruses and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are co-circulating.

Titled Influenza and COVID-19, the new section in the guideline discusses:

  • Influenza vaccination for those with COVID-19
  • Clinical presentation similarities/differences between the 2 viruses
  • Potential for co-infection with influenza and SARS-CoV-2
  • Testing for influenza and SARS-CoV-2 in patients with acute respiratory symptoms
  • Treatment of influenza in the setting of co-circulatling SARS-CoV-2

Get a top-line review in the short slideshow that follows.

Related Videos
Jeff Andrews, MD